## **Core Concept**
Pseudomyxoma peritonei (PMP) is a clinical syndrome characterized by recurrent mucinous ascites causing abdominal distension. It often arises as a complication of a mucinous tumor of the appendix or ovary. The condition involves the accumulation of mucin in the peritoneal cavity, leading to mass effect and potential bowel obstruction.
## **Why the Correct Answer is Right**
The correct answer, ** mucinous cystadenocarcinoma of the ovary**, is right because pseudomyxoma peritonei is indeed associated with mucinous tumors, particularly those of the appendix and ovary. Mucinous cystadenocarcinomas are known to produce large amounts of mucin. When these tumors rupture, they can disseminate mucin-producing cells throughout the peritoneal cavity, leading to the characteristic clinical presentation of PMP.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Serous cystadenocarcinoma of the ovary is not typically associated with pseudomyxoma peritonei. Serous tumors are more commonly linked to ascites but not specifically to mucinous ascites or PMP.
- **Option B:** Germ cell tumors are a diverse group of ovarian tumors, including dysgerminomas, yolk sac tumors, and teratomas. While they can cause abdominal distension due to tumor growth or ascites, they are not characteristically associated with PMP.
- **Option C:** Brenner tumors are usually benign and not commonly linked to PMP. They are epithelial tumors but do not typically produce mucin in the quantities seen with mucinous tumors.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that pseudomyxoma peritonei can also originate from appendiceal tumors, and the clinical presentation can mimic that of a mucinous ovarian tumor. The condition often requires a combination of surgical debulking and possibly intraperitoneal chemotherapy for management.
## **Correct Answer:** . mucinous cystadenocarcinoma of the ovary
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.